Invesco NASDAQ Biotech UCITS ETF | SBIO

Performance History31/12/2018
Growth of 1,000 (GBP) Advanced Graph
Invesco NASDAQ Biotech UCITS ETF
          | 
          SBIO
Fund-17.7-6.110.9-5.8
+/-Cat-4.3-2.20.62.1
+/-B’mrk-3.8-10.93.0-7.5
 
Key Stats
Closing Price
22/01/2019
 USD 34.76
Day Change -1.67%
Morningstar Category™ Sector Equity Biotechnology
Volume 4122
Exchange LONDON STOCK EXCHANGE, THE
ISIN IE00BQ70R696
Fund Size (Mil)
18/01/2019
 USD 353.82
Share Class Size (Mil)
18/01/2019
 USD 353.82
Ongoing Charge
25/05/2018
  0.40%
Investment Objective: Invesco NASDAQ Biotech UCITS ETF | SBIO
The Fund aims to provide the performance of the NASDAQ Biotechnology Index1 (the “Benchmark Index”). The Benchmark Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market.
Returns
Trailing Returns (GBP)22/01/2019
YTD11.57
3 Years Annualised8.09
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
-
-
Inception Date
07/11/2014
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Invesco NASDAQ Biotech UCITS ETF | SBIO31/12/2018
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock100.000.00100.00
Bond0.000.000.00
Property0.000.000.00
Cash0.000.000.00
Other0.000.000.00
Top 5 Regions%
United States96.79
Eurozone1.26
United Kingdom0.68
Asia - Emerging0.53
Europe - ex Euro0.31
Top 5 Sectors%
Healthcare99.96
Basic Materials0.04
Top 5 HoldingsSector%
TRS NASDAQ Biotechnology TR USD100.00
Invesco NASDAQ Biotech UCITS ETF | SBIO